Evaluating the effectiveness of a procedure for pelvic congestion syndrome
Effectiveness of Endovascular Plug Embolization in Pelvic Congestion Syndrome
This study is testing if a procedure called endovascular plug embolization can help women with pelvic congestion syndrome feel better by reducing their chronic pelvic pain.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 44 (estimated) |
| Ages | 18 Years to 65 Years |
| Sex | Female |
| Sponsor | Kanuni Sultan Suleyman Training and Research Hospital Academic / other |
| Drugs / interventions | chemotherapy, radiation |
| Locations | 1 site (Istanbul) |
| Trial ID | NCT06553014 on ClinicalTrials.gov |
What this trial studies
This observational study examines the effectiveness of endovascular plug embolization in patients diagnosed with pelvic congestion syndrome (PCS), a condition characterized by chronic pelvic pain and dilated pelvic veins. Conducted at Kanuni Sultan Süleyman Training and Research Hospital, the study retrospectively analyzes data from 32 female patients who underwent this procedure between January 2023 and March 2024. Inclusion criteria focus on patients aged 18 and older with persistent abdominopelvic pain and specific ultrasound findings, while various gynecological and medical conditions serve as exclusion criteria.
Who should consider this trial
Good fit: Ideal candidates for this study are women aged 18 and older with chronic pelvic pain lasting more than six months and evidence of dilated pelvic veins.
Not a fit: Patients with certain gynecological conditions, previous surgeries, or other specified medical issues may not benefit from this study.
Why it matters
Potential benefit: If successful, this procedure could significantly alleviate chronic pelvic pain for patients suffering from pelvic congestion syndrome.
How similar studies have performed: While the approach of using endovascular procedures for pelvic congestion syndrome is not widely established, similar studies have shown promising results in managing chronic pelvic pain.
Eligibility criteria
Show full inclusion / exclusion criteria
exclusion criteria: -Gynecologically, patients with leiomyoma, pelvic inflammatory disease, endometriosis , postoperative adhesion, * Patients who have undergone urological and gynecological surgery, * Patients with chronic renal failure, * Patients with known allergies to the drugs used during the procedure , * Patients with abdominopelvic trauma, malignancy or its history, * Patients with a history of radiotherapy chemotherapy, * Patients with known psychiatric disease, * Pregnant women, * Breastfeeding women, * Patients with fibromyalgia , * Known lumbar disc herniation, scoliosis, facet syndrome, sacroiliac dysfunction, and patients with genitourinary and gastrointestinal diseases were excluded from the study.
Where this trial is running
Istanbul
- Kanuni Sultan Süleyman Training and Research Hospital — Istanbul, Turkey (Recruiting)
Study contacts
- Study coordinator: halil ibrahim altun, physians
- Email: halilibrahim_altun@yahoo.com
- Phone: +905072774773
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.